Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules
SUMMARY
Aminoglycosides (AGs) are long-known molecules successfully used against Gram-negative pathogens. While their use declined with the discovery of new antibiotics, they are now classified as critically important molecules because of their effectiveness against multidrug-resistant bacteria. While they can efficiently cross the Gram-negative envelope, the mechanism of AG entry is still incompletely understood, although this comprehension is essential for the development of new therapies in the face of the alarming increase in antibiotic resistance. Increasing antibiotic uptake in bacteria is one strategy to enhance effective treatments. This review aims, first, to consolidate old and recent knowledge about AG uptake; second, to explore the connection between AG-dependent bacterial stress and drug uptake; and finally, to present new strategies of potentiation of AG uptake for more efficient antibiotic therapies. In particular, we emphasize on the connection between sugar transport and AG potentiation.
Топ-30
Журналы
|
1
2
3
4
5
6
7
|
|
|
bioRxiv
7 публикаций, 11.67%
|
|
|
mBio
4 публикации, 6.67%
|
|
|
ACS Infectious Diseases
3 публикации, 5%
|
|
|
International Journal of Antimicrobial Agents
3 публикации, 5%
|
|
|
Science advances
2 публикации, 3.33%
|
|
|
mSystems
2 публикации, 3.33%
|
|
|
Nature Communications
2 публикации, 3.33%
|
|
|
Frontiers in Microbiology
2 публикации, 3.33%
|
|
|
Bioconjugate Chemistry
2 публикации, 3.33%
|
|
|
Frontiers in Drug Discovery
1 публикация, 1.67%
|
|
|
Antimicrobial Agents and Chemotherapy
1 публикация, 1.67%
|
|
|
European Polymer Journal
1 публикация, 1.67%
|
|
|
ChemMedChem
1 публикация, 1.67%
|
|
|
Journal of Basic Microbiology
1 публикация, 1.67%
|
|
|
Pharmaceutics
1 публикация, 1.67%
|
|
|
International Journal of Biological Macromolecules
1 публикация, 1.67%
|
|
|
Current Opinion in Infectious Diseases
1 публикация, 1.67%
|
|
|
Cureus
1 публикация, 1.67%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
1 публикация, 1.67%
|
|
|
Food Reviews International
1 публикация, 1.67%
|
|
|
Infection, Genetics and Evolution
1 публикация, 1.67%
|
|
|
Bioelectrochemistry
1 публикация, 1.67%
|
|
|
Frontiers in Veterinary Science
1 публикация, 1.67%
|
|
|
Antonie van Leeuwenhoek
1 публикация, 1.67%
|
|
|
Natural Products and Bioprospecting
1 публикация, 1.67%
|
|
|
Molecular Biology and Evolution
1 публикация, 1.67%
|
|
|
World Journal of Microbiology and Biotechnology
1 публикация, 1.67%
|
|
|
Current Microbiology
1 публикация, 1.67%
|
|
|
Antibiotics
1 публикация, 1.67%
|
|
|
Reviews of Environmental Contamination and Toxicology
1 публикация, 1.67%
|
|
|
1
2
3
4
5
6
7
|
Издатели
|
2
4
6
8
10
12
|
|
|
Elsevier
11 публикаций, 18.33%
|
|
|
Springer Nature
10 публикаций, 16.67%
|
|
|
American Society for Microbiology
7 публикаций, 11.67%
|
|
|
openRxiv
7 публикаций, 11.67%
|
|
|
American Chemical Society (ACS)
5 публикаций, 8.33%
|
|
|
Frontiers Media S.A.
4 публикации, 6.67%
|
|
|
MDPI
4 публикации, 6.67%
|
|
|
Wiley
3 публикации, 5%
|
|
|
Taylor & Francis
2 публикации, 3.33%
|
|
|
American Association for the Advancement of Science (AAAS)
2 публикации, 3.33%
|
|
|
Oxford University Press
2 публикации, 3.33%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 1.67%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 публикация, 1.67%
|
|
|
OAE Publishing Inc.
1 публикация, 1.67%
|
|
|
2
4
6
8
10
12
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.